Financing an Ambulatory Surgery Center Acquisition

ASCs are SBA-ineligible but command strong conventional and PE-backed financing structures. Learn which capital options fit your deal size, ownership model, and clinical risk profile.

Find Ambulatory Surgery Center Deals SBA Calculator →

Acquiring an ambulatory surgery center requires a financing strategy tailored to healthcare's regulatory complexity. With valuations ranging 5–9x EBITDA and SBA financing unavailable, buyers typically rely on conventional senior debt, mezzanine capital, or PE-backed equity structures. Lenders focus heavily on Medicare certification status, payer mix stability, physician retention agreements, and EBITDA margins of 20–35% when underwriting ASC transactions.

Financing Options for Ambulatory Surgery Center Acquisitions

Conventional Senior Debt (Healthcare-Focused Lenders)

$1M–$8M7.5%–10.5% (floating or fixed, 5–7 year term)

Bank or non-bank senior secured loans from healthcare specialty lenders underwriting ASC cash flows based on Medicare certification, payer contract quality, and trailing EBITDA. Typical LTV is 50–65% of enterprise value.

Pros

Lowest cost of capital available for ASC acquisitions with strong EBITDA margins and clean compliance history
Healthcare-specialized lenders understand payer contract analysis and physician ownership structures
Preserves equity ownership for physician rollover partners or PE sponsors in partial buyout structures

Cons

×Requires 3 years of audited financials and clean Medicare/Medicaid compliance history — no shortcuts
×Lenders heavily discount revenue concentration from one or two surgeons, limiting borrowing capacity
×Covenant requirements may restrict distributions or additional acquisitions during loan term

Mezzanine Debt / Subordinated Healthcare Financing

$2M–$6M13%–18% (cash pay plus PIK component; 4–6 year term)

Subordinated debt placed behind senior loans to bridge equity gaps in larger ASC acquisitions. Common in PE-sponsored roll-ups where equity is preserved for physician partners and management incentive plans.

Pros

Fills capital stack gaps in deals with high EBITDA multiples (7–9x) where senior debt alone is insufficient
Non-dilutive compared to equity; physician rollover ownership percentages are preserved
Mezzanine providers with healthcare expertise can move quickly when Medicare certification and accreditation are clean

Cons

×High blended cost of capital can compress returns if case volumes decline or payer contracts are renegotiated downward
×Requires strong EBITDA coverage — typically 1.25x DSCR minimum after senior debt service
×Often includes equity warrants or PIK interest that increases total repayment burden over the hold period

Private Equity Sponsored Acquisition (Equity-Led Capital)

$3M–$20M+ total enterprise valueTarget IRR of 20–30% over 4–7 year hold; blended cost of capital varies by leverage ratio

PE platforms acquire controlling or majority ASC equity, often combining sponsor equity with senior debt. Physicians retain rollover equity (typically 20–40%) to align incentives and satisfy regulatory ownership requirements.

Pros

PE sponsors provide operational infrastructure, revenue cycle expertise, and payer contract negotiation leverage for multi-site platforms
Physician rollover equity creates meaningful second-bite liquidity at platform exit — often 3–5x initial rollover value
Access to bolt-on acquisition capital for add-on ASCs accelerates revenue growth and EBITDA scale

Cons

×PE ownership may conflict with physician autonomy and clinical independence — a common post-close friction point
×Requires surgeon partners to reach consensus on exit terms and rollover percentages, which can delay deal timelines significantly
×PE platforms prioritize scale and exit multiples; single-site ASCs with limited expansion potential may struggle to attract top-tier sponsors

Sample Capital Stack

$6.5M (representing 7x EBITDA on $928K trailing EBITDA for a multi-specialty ASC with 3 OR suites and diversified payer mix)

Purchase Price

Approximately $58,000/month combined senior and mezzanine debt service (blended ~10.8% cost of debt)

Monthly Service

1.33x based on $928K EBITDA against $696K annual debt service — above typical 1.25x minimum lender threshold

DSCR

Senior Debt: $3.9M (60%) at 9.0% | Mezzanine Debt: $1.3M (20%) at 15.0% | Physician Rollover Equity: $650K (10%) | Buyer Equity: $650K (10%)

Model your own deal structure →

Lender Tips for Ambulatory Surgery Center Acquisitions

1Lead with Medicare certification and AAAHC or Joint Commission accreditation documentation upfront — lenders will not advance without verified, active accreditation status regardless of EBITDA quality.
2Prepare a 36-month case volume and payer mix analysis showing revenue diversification across specialties and surgeons; concentration above 40% in one physician is a hard underwriting concern.
3Document physician retention agreements, rollover equity commitments, and any restrictive covenants before approaching lenders — key-man risk is the top reason ASC deals fail credit committee review.
4Resolve all open CMS audits, overpayment demands, or state compliance violations before lender engagement; disclosed but unresolved regulatory issues will stall underwriting and increase lender pricing.

Frequently Asked Questions

Are ambulatory surgery centers eligible for SBA 7(a) or SBA 504 financing?

No. ASCs are classified as healthcare facilities involved in patient care and are explicitly excluded from SBA loan eligibility. Buyers must use conventional healthcare lenders, mezzanine debt, or PE-backed equity structures.

What EBITDA margin do lenders require to finance an ASC acquisition?

Most healthcare lenders require sustained EBITDA margins of 20% or higher with a minimum 1.25x DSCR post-financing. Margins above 25% significantly improve leverage capacity and lender appetite for the transaction.

How does physician rollover equity affect ASC acquisition financing?

Rollover equity (typically 20–40% retained by surgeons) reduces the external capital required and signals physician commitment to lenders. It also helps satisfy federal healthcare regulations limiting non-physician ownership in certain ASC structures.

What is a realistic timeline to close an ASC acquisition financing?

Most ASC acquisitions require 90–150 days from LOI to close due to regulatory review, physician consent, payer contract assignment, and lender underwriting of Medicare certification and compliance history — longer than most non-healthcare deals.

More Ambulatory Surgery Center Guides

Buy a Ambulatory Surgery Center Business →Valuation Guide →SBA Loan Guide →Deal Structure →Common Mistakes →SBA Calculator →Deal Structure Builder →

Ready to finance your Ambulatory Surgery Center acquisition?

DealFlow OS surfaces acquisition targets and helps you structure the deal. Free to join.

Start finding deals — free

No credit card required